These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7423341)

  • 41. [IgE (author's transl)].
    Kobayashi M; Kanŏ S; Kondo T
    Rinsho Byori; 1975 Dec; 23(12):929-31. PubMed ID: 1240988
    [No Abstract]   [Full Text] [Related]  

  • 42. [Assay of human serum IgE by reversed passive hemagglutination test (author's transl)].
    Yu YC; Liu HY; Zhang YX; Fang MY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1980 Sep; 2(3):192-6. PubMed ID: 6451321
    [No Abstract]   [Full Text] [Related]  

  • 43. Polyclonal immunoglobulin E levels are correlated with hemoglobin values and overall survival in patients with multiple myeloma.
    Matta GM; Battaglio S; Dibello C; Napoli P; Baldi C; Ciccone G; Coscia M; Boccadoro M; Massaia M
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5348-54. PubMed ID: 17875762
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enzyme-linked immunosorbent assay for measuring serum IgE.
    Hoshi K; Mizushima Y; Shoji Y; Kudo T; Ogita T
    Experientia; 1980 Sep; 36(9):1122. PubMed ID: 7418858
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunoglobulin D multiple myeloma in our hospital--a rare occurrence.
    Tan LK; Suri R; Lim HL; Ong SK
    Singapore Med J; 2000 Oct; 41(10):500-3. PubMed ID: 11281443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new case of IgE multiple myeloma with review of literature.
    Vignon G; Cognée AS; Carrere F; Masson I; Borde F; Augereau PF; Aucher P; Lellouche F
    Ann Biol Clin (Paris); 2017 Aug; 75(4):442-444. PubMed ID: 28751289
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Multiple myeloma and the anion gap (author's transl)].
    Pigrau Serrallach C; Bosch Gil JA; Durán JR; Pahissa Berga A; Tornos Solano J; Zuazu Nagore FJ
    Med Clin (Barc); 1981 Oct; 77(6):243-6. PubMed ID: 7321639
    [No Abstract]   [Full Text] [Related]  

  • 48. [Plasmocytic immunocytoma with a course of 20.5 years and tumour duplicity (author's transl)].
    Dyrhon V; Dyrhonová V
    Cas Lek Cesk; 1980 Nov; 119(46):1257-9. PubMed ID: 7459951
    [No Abstract]   [Full Text] [Related]  

  • 49. [Testicular metastasis of multiple myeloma: a case report (author's transl)].
    Yoshimoto J; Ohkita K; Matsumura Y; Ohhashi T
    Nihon Hinyokika Gakkai Zasshi; 1979 Jul; 70(7):828-32. PubMed ID: 502105
    [No Abstract]   [Full Text] [Related]  

  • 50. [Amyloid intestinal pseudo-obstruction as initial manifestation of IgA multiple myeloma].
    Domingo-García P; Pardo-García JL; Martínez-Albaladejo M; Moreno-Requena J
    An Med Interna; 1995 Jun; 12(6):283-5. PubMed ID: 7548645
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Diagnosis versus differential diagnosis of multiple myeloma].
    Bessmel'tsev SS
    Vopr Onkol; 2004; 50(4):406-16. PubMed ID: 15605762
    [No Abstract]   [Full Text] [Related]  

  • 52. [Multiple myeloma without the demonstration of paraprotein].
    Sedlácková M
    Vnitr Lek; 1974 Oct; 20(10):1006-9. PubMed ID: 4424739
    [No Abstract]   [Full Text] [Related]  

  • 53. Skin involvement in immunoglobulin E multiple myeloma.
    Wozney JL; Ahmed F; Bayerl MG; Ehmann WC; Talamo G
    J Clin Oncol; 2009 Feb; 27(4):637-8. PubMed ID: 19064952
    [No Abstract]   [Full Text] [Related]  

  • 54. [Multiple myeloma (author's transl)].
    Ohtsubo Y; Okada Y; Kameyama Y; Matsui K; Hamachi R
    Aichi Gakuin Daigaku Shigakkai Shi; 1977 Dec; 15(3):310-5. PubMed ID: 281159
    [No Abstract]   [Full Text] [Related]  

  • 55. Sialyltransferase activity in AF10 myeloma cell line.
    Cohen AM; Allalouf D; Wacks T; Lehrer N; Levinsky H
    Biochem Med Metab Biol; 1990 Oct; 44(2):101-5. PubMed ID: 2252611
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Studies on serum histaminopexy of ocular diseases. II. Especially the relation between serum histaminopexy and the level of IgE (author's transl)].
    Nakajima N
    Nippon Ganka Gakkai Zasshi; 1973 Nov; 77(11):1936-40. PubMed ID: 4799423
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical characteristics and treatment outcomes in IgE multiple myeloma: A case-control study.
    Jurczyszyn A; Castillo JJ; Vesole DH; Liu J; Avivi I; Waszczuk-Gajda A; Lech-Maranda E; Gentile M; Mikala G; Guerrero-Garcia T; Suska A; Gertz MA
    Am J Hematol; 2018 Sep; 93(9):E238-E241. PubMed ID: 29989240
    [No Abstract]   [Full Text] [Related]  

  • 59. [Multiple myeloma treatment with adriablastin and BCNU (author's transl)].
    Sedlácková M
    Cas Lek Cesk; 1980 Sep; 119(38):1036-8. PubMed ID: 7471147
    [No Abstract]   [Full Text] [Related]  

  • 60. [Plasma cell myeloma associated with the interference of M-protein to the clotting mechanism (author's transl)].
    Ueda N; Machida K; Yube T; Takaoka M; Niiya K; Yorimitu S; Taguchi H; Shiomi F
    Rinsho Ketsueki; 1980 Sep; 21(9):1359-64. PubMed ID: 7452924
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.